Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
pembrolizumab | 1.74 | 0.7 | 5825 | 17 | 13 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
pembrolizumab | 0.89 | 1 | 3074 | 86 |
pembrolizumab side effects | 1 | 0.8 | 8886 | 70 |
pembrolizumab package insert | 1.35 | 0.3 | 4674 | 70 |
pembrolizumab keytruda | 1.87 | 0.1 | 8504 | 33 |
pembrolizumab moa | 0.62 | 1 | 719 | 51 |
pembrolizumab cost | 1.64 | 0.1 | 5990 | 52 |
pembrolizumab mechanism of action | 0.93 | 0.1 | 5868 | 89 |
pembrolizumab immunotherapy | 0.36 | 0.5 | 804 | 5 |
pembrolizumab pi | 1.22 | 0.9 | 2937 | 60 |
pembrolizumab warnings | 1.45 | 0.4 | 9878 | 29 |
pembrolizumab fda approval | 1.11 | 0.8 | 192 | 33 |
pembrolizumab action | 1.58 | 0.3 | 2854 | 76 |
pembrolizumab j code | 0.52 | 0.3 | 6629 | 20 |
pembrolizumab nivolumab difference | 0.86 | 0.7 | 9913 | 83 |
pembrolizumab and nivolumab | 1.99 | 0.6 | 1985 | 94 |
pembrolizumab fda | 1.89 | 0.4 | 455 | 77 |
pembrolizumab ema | 1.72 | 0.9 | 6586 | 91 |
pembrolizumab cervical cancer | 1.92 | 0.3 | 91 | 23 |
pembrolizumab versus nivolumab for melanoma | 1.39 | 0.6 | 5089 | 28 |
pembrolizumab keytruda and nivolumab opdivo | 1.11 | 0.4 | 1046 | 22 |
pembrolizumab prescribing information | 0.6 | 0.6 | 1434 | 28 |
pembrolizumab breast cancer | 0.7 | 0.5 | 8988 | 7 |
pembrolizumab 200 mg | 0.87 | 0.6 | 6346 | 71 |
pembrolizumab eviq | 1.38 | 0.5 | 7583 | 67 |
pembrolizumab tnbc | 1.53 | 0.6 | 9158 | 17 |